---
title: 'Innovation at the Interface between Academia and Industry: The BioMed X Model'
date: '2024-09-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39235485/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240905183429&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: In the evolving landscape of biomedical research, the convergence of
  molecular biology and translational medicine has ushered in a new era of pharmaceutical
  innovation. This paradigm shift, characterized by significant advances in targeted
  therapies and gene editing, emphasizes the critical role of integrating academic
  research - and academic researchers - within industry settings. Contemporary innovation
  models are moving beyond traditional, corporation-centered frameworks, adopting
  more ...
disable_comments: true
---
In the evolving landscape of biomedical research, the convergence of molecular biology and translational medicine has ushered in a new era of pharmaceutical innovation. This paradigm shift, characterized by significant advances in targeted therapies and gene editing, emphasizes the critical role of integrating academic research - and academic researchers - within industry settings. Contemporary innovation models are moving beyond traditional, corporation-centered frameworks, adopting more ...